Takeda Pharmaceutical

4502.TPharmaceutical

Key numbers · FY ended 2026-03

Revenue¥4.51T-1.7% YoY Operating income¥6.2bn-98.2% YoY Net income (owners)−¥152.4bn-241.2% YoY Total assets¥15.51T+8.9% YoY EPS (basic)¥-96.75-241.5% YoY

Full financial history and reports →

Stock price4502 · View chart ↗

Open the price chart on TradingView.

Latest filings

Tue, May 19 · JST1 filing

15:02MATERIALTakeda Pharmaceutical · Event with a material impact on financial position

Thu, Jan 30 · JST1 filing

16:02MATERIALTakeda Pharmaceutical · Change of representative director

Thu, Sep 26 · JST1 filing

15:06MATERIALTakeda Pharmaceutical · Change in parent company or specified subsidiary

All filings →

Major holders (5%+) · 0

Holder	Stake	Change	Filed

No holder currently reports 5% or more.

Each holder's own ratio from its most recent large-shareholding report.